Lorusso G - Search Results

1

Rationale, problems and perspectives in anti-angiogenic therapy.

Lorusso G, Dell'Eva R, Vené R, Pfeffer U, Albini A. Lorusso G, et al. Tumori. 2001 Nov-Dec;87(6):S17-9. Tumori. 2001. PMID: 11989611 Review. No abstract available.

2

Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids.

Sogno I, Vannini N, Lorusso G, Cammarota R, Noonan DM, Generoso L, Sporn MB, Albini A. Sogno I, et al. Among authors: lorusso g. Recent Results Cancer Res. 2009;181:209-12. doi: 10.1007/978-3-540-69297-3_19. Recent Results Cancer Res. 2009. PMID: 19213570 Review.

3

Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent.

Lorusso G, Vannini N, Sogno I, Generoso L, Garbisa S, Noonan DM, Albini A. Lorusso G, et al. Eur J Cancer. 2009 May;45(8):1474-84. doi: 10.1016/j.ejca.2009.01.014. Epub 2009 Feb 14. Eur J Cancer. 2009. PMID: 19223175

4

Cytokines and chemokines as regulators of angiogenesis in health and disease.

Benelli R, Lorusso G, Albini A, Noonan DM. Benelli R, et al. Among authors: lorusso g. Curr Pharm Des. 2006;12(24):3101-15. doi: 10.2174/138161206777947461. Curr Pharm Des. 2006. PMID: 16918437 Review.

5

Natural and synthetic agents targeting inflammation and angiogenesis for chemoprevention of prostate cancer.

Araldi EM, Dell'aica I, Sogno I, Lorusso G, Garbisa S, Albini A. Araldi EM, et al. Among authors: lorusso g. Curr Cancer Drug Targets. 2008 Mar;8(2):146-55. doi: 10.2174/156800908783769382. Curr Cancer Drug Targets. 2008. PMID: 18336198 Review.

6

Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy.

Morini M, Albini A, Lorusso G, Moelling K, Lu B, Cilli M, Ferrini S, Noonan DM. Morini M, et al. Among authors: lorusso g. Gene Ther. 2004 Feb;11(3):284-91. doi: 10.1038/sj.gt.3302175. Gene Ther. 2004. PMID: 14737088

7

The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent.

Vannini N, Lorusso G, Cammarota R, Barberis M, Noonan DM, Sporn MB, Albini A. Vannini N, et al. Among authors: lorusso g. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3139-46. doi: 10.1158/1535-7163.MCT-07-0451. Epub 2007 Dec 7. Mol Cancer Ther. 2007. PMID: 18065492

8

Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model.

Vannini N, Pfeffer U, Lorusso G, Noonan DM, Albini A. Vannini N, et al. Among authors: lorusso g. Curr Pharm Des. 2008;14(3):221-5. doi: 10.2174/138161208783413248. Curr Pharm Des. 2008. PMID: 18220832 Review.

9

Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target.

Albini A, Brigati C, Ventura A, Lorusso G, Pinter M, Morini M, Mancino A, Sica A, Noonan DM. Albini A, et al. Among authors: lorusso g. J Transl Med. 2009 Jan 14;7:5. doi: 10.1186/1479-5876-7-5. J Transl Med. 2009. PMID: 19144161 Free PMC article.

10

Hyperforin blocks neutrophil activation of matrix metalloproteinase-9, motility and recruitment, and restrains inflammation-triggered angiogenesis and lung fibrosis.

Dell'Aica I, Niero R, Piazza F, Cabrelle A, Sartor L, Colalto C, Brunetta E, Lorusso G, Benelli R, Albini A, Calabrese F, Agostini C, Garbisa S. Dell'Aica I, et al. Among authors: lorusso g. J Pharmacol Exp Ther. 2007 May;321(2):492-500. doi: 10.1124/jpet.106.116459. Epub 2007 Feb 8. J Pharmacol Exp Ther. 2007. PMID: 17289834 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters